Role of liver fluke granulin in cholangiocarcinogenesis

肝吸虫颗粒蛋白在胆管癌发生中的作用

基本信息

  • 批准号:
    8549169
  • 负责人:
  • 金额:
    $ 30.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-21 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Infection with the food-borne liver fluke parasites Opisthorchis viverrini and Clonorchis sinensis is a strong risk factor for cholangiocarcinoma (CCA), bile duct cancer, in Thailand, Laos and other locations in East Asia where infection is endemic. As determined by the World Health Organization's International Agency for Research on Cancer, no stronger link exists between human malignancy and a eukaryotic pathogen than that of CCA and liver fluke infection. CCA usually presents late, is a challenge for diagnosis, metastasizes readily and has high mortality - features highlighting the necessity to understand why and how infection with a food- borne parasite leads to a devastating liver cancer. The transformation from chronic infection with O. viverrini to CCA is multi-factorial, but one importan factor appears to be secretion into the bile ducts of parasite proteins with mitogenic properties, driving local proliferation of biliary and hepatic cells and creating a tumorigenic environment. We have identified a homologue of human granulin, a potent growth factor involved in cell proliferation and wound healing, in the excretory/secretory (ES) products of the parasite. O. viverrini granulin, termed Ov-GRN-1, is widely expressed in fluke tissues, including gut and tegument. Furthermore, Ov-GRN-1 locates in situ to the surface of biliary epithelial cells of hamsters experimentally infected with O. viverrini. Recombinant Ov-GRN-1 stimulates proliferation of murine fibroblasts and human CCA cell lines at nanomolar concentrations that can be inhibited by MAPK kinase inhibitors. Antibodies to Ov-GRN-1 inhibited the ability of O. viverrini ES products to induce proliferation of mammalian cell lines in vitro, indicating that Ov-GRN-1 is the major growth factor present in O. viverrini ES. This was the first report of a secreted growth factor from a parasitic worm that induces proliferation of host cells. Significantly, these new findings support a role for this fluke protein in establishment of a tumorigenic environment that may ultimately manifest as CCA. Here we plan to test this hypothesis with a particular emphasis on the role of Ov-GRN-1 in cell cycle progression and wound repair. We propose also to characterize transcriptional and translational responses of cholangiocytes and CCA cell lines to Ov-GRN-1 using proteomic and genomic microarray approaches to understand signaling and other pathways by which liver fluke granulin drives host cell proliferation. In addition, we propose to use gene silencing and vaccination of hamsters to determine whether Ov-GRN-1 is the major, or even sole, growth factor secreted by the parasite. These studies will determine whether Ov-GRN-1 is the Achilles' heel of this parasite that could be exploited as an anti-fluke and indeed anti-cancer vaccine.
描述(由申请方提供):食源性肝吸虫寄生虫猫尾后睾吸虫和华支睾吸虫感染是泰国、老挝和东亚其他感染流行地区胆管癌(CCA)、胆管癌的强风险因素。正如世界卫生组织的国际癌症研究机构所确定的那样,人类恶性肿瘤与真核病原体之间的联系没有比CCA和肝吸虫感染更强的联系。CCA通常出现较晚,对诊断来说是一个挑战,容易转移,死亡率高-这些特征突出了了解食源性寄生虫感染为何以及如何导致毁灭性肝癌的必要性。 慢性感染O.灵猫体对CCA的促增殖作用是多因素的,但一个重要因素似乎是具有促有丝分裂特性的寄生虫蛋白分泌到胆管中,驱动胆管和肝细胞的局部增殖并产生致瘤环境。我们 已经在寄生虫的排泄/分泌(ES)产物中鉴定了人颗粒蛋白的同源物,人颗粒蛋白是参与细胞增殖和伤口愈合的有效生长因子。O.被称为Ov-GRN-1的灵猫颗粒蛋白广泛表达于吸虫组织中,包括肠和被膜。Ov-GRN-1在感染O.维韦里尼。重组Ov-GRN-1刺激小鼠成纤维细胞和人CCA细胞系在纳摩尔浓度下的增殖,该浓度可被MAPK激酶抑制剂抑制。抗Ov-GRN-1抗体可抑制O.提示Ov-GRN-1是存在于O.灵猫ES.这是第一次报告的分泌生长因子从寄生虫,诱导宿主细胞增殖。值得注意的是,这些新发现支持了这种吸虫蛋白在建立可能最终表现为CCA的致瘤环境中的作用。 在这里,我们计划测试这一假设,特别强调Ov-GRN-1在细胞周期进展和伤口修复中的作用。我们还建议使用蛋白质组学和基因组微阵列方法来表征胆管细胞和CCA细胞系对Ov-GRN-1的转录和翻译反应,以了解肝吸虫颗粒蛋白驱动宿主细胞增殖的信号传导和其他途径。此外,我们建议使用基因沉默和接种仓鼠,以确定是否Ov-GRN-1是主要的,甚至是唯一的,寄生虫分泌的生长因子。这些研究将确定Ov-GRN-1是否是这种寄生虫的阿基里斯之踵,可以被用作抗吸虫和抗癌疫苗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul J Brindley其他文献

Programmed knockout mutation of liver fluke granulin , Ov-grn-1 , attenuates 1 virulence and impedes malignant transformation during chronic 2 opisthorchiasis 3 4 5
肝吸虫颗粒蛋白 , Ov-grn-1 的程序性敲除突变,减弱 1 毒力并阻止慢性 2 阿片吸虫病期间的恶性转化 3 4 5
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sujittra Chaiyadet;S. Tangkawattana;M. Smout;Wannaporn;Ittiprasert;V. Mann;Raksawan Deenonpoe;P. Arunsan;Alex;Loukas;Paul J Brindley;T. Laha
  • 通讯作者:
    T. Laha

Paul J Brindley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul J Brindley', 18)}}的其他基金

Antibiotic selection for schistosome transgenesis
血吸虫转基因的抗生素选择
  • 批准号:
    8849840
  • 财政年份:
    2014
  • 资助金额:
    $ 30.87万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8371253
  • 财政年份:
    2012
  • 资助金额:
    $ 30.87万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    9107394
  • 财政年份:
    2012
  • 资助金额:
    $ 30.87万
  • 项目类别:
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
针对寄生虫与宿主的通讯来对抗肝吸虫诱发的胆管癌
  • 批准号:
    10453668
  • 财政年份:
    2012
  • 资助金额:
    $ 30.87万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8707832
  • 财政年份:
    2012
  • 资助金额:
    $ 30.87万
  • 项目类别:
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
针对寄生虫与宿主的通讯来对抗肝吸虫诱发的胆管癌
  • 批准号:
    10226900
  • 财政年份:
    2012
  • 资助金额:
    $ 30.87万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8716242
  • 财政年份:
    2012
  • 资助金额:
    $ 30.87万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7799460
  • 财政年份:
    2009
  • 资助金额:
    $ 30.87万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7846579
  • 财政年份:
    2009
  • 资助金额:
    $ 30.87万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7211226
  • 财政年份:
    2007
  • 资助金额:
    $ 30.87万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 30.87万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 30.87万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 30.87万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.87万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 30.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 30.87万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 30.87万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 30.87万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 30.87万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 30.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了